Pediatr Gastroenterol Hepatol Nutr.
2013 Mar;16(1):22-27. 10.5223/pghn.2013.16.1.22.
Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
- Affiliations
-
- 1Department of Pediatrics, Gyeongsang National University School of Medicine, Jinju, Korea. csassi@hanmail.net
- KMID: 1428803
- DOI: http://doi.org/10.5223/pghn.2013.16.1.22
Abstract
- The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Gut microbiota and nonalcoholic fatty liver disease
- Regulation of Obesity and Non-alcoholic Fatty Liver Diseases by Modulation of the Gut Microbiota Through Inflammasome; its Mechanism and Potential for Clinical Use
- The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease
- Gut Microbiota and Metabolic Disorders
- Recent Epidemiology of Nonalcoholic Fatty Liver Disease
